In addition, considering that both mast cells and TSP1 modulate inflammatory pathways, drugs like corticosteroids or newer-generation non-steroidal anti-inflammatory agents could be explored for their efficacy in reducing inflammation, a key driver of AMD [112]. The gene discussed is THBS1; the disease is age-related macular degeneration.